SYR-472 Open-label Study

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221978

Enrollment

Registered

2012-12-13

Start date

2012-12-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

investigational material(s) Generic name etc : SYR-472 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The participant is judged to be capable of understanding and complying with protocol requirements by the investigator or subinvestigator. 2. The participant can sign and date a written, informed consent form prior to the initiation of any study procedures.

Exclusion criteria

Exclusion criteria: 1. The participant has concurrent serious cardiac disease, serious cerebrovascular disorder, or serious pancreatic or hematological disease. 2. The participant is assessed to be ineligible for the study by the investigator or subinvestigator.

Design outcomes

Primary

Measure	Time frame
Blood Glucose Time Frame: 7 days	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026